Helen Sabzevari's most recent trade in Precigen Inc was a trade of 500,000 Restricted Stock Units done . Disclosure was reported to the exchange on June 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 500,000 | 500,000 | - | - | Restricted Stock Units | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2025 | 1,000,000 | 1,000,000 | - | - | Option to Purchase Common Stock (Right to Buy) | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2025 | 1,079,137 | 3,838,246 (2%) | 0% | - | Common Stock | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2025 | 1,079,137 | 0 | - | - | Restricted Stock Units | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.45 per share. | 16 May 2025 | 521,224 | 3,317,022 (1%) | 0% | 1.5 | 755,775 | Common Stock |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 1,079,137 | 1,079,137 | - | - | Restricted Stock Units | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 825,000 | 3,046,076 (1%) | 0% | 0 | Common Stock | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.30 per share. | 29 Jan 2025 | 286,967 | 2,759,109 (1%) | 0% | 1.3 | 373,057 | Common Stock |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 1,803,000 | 1,803,000 | - | - | Option to Purchase Common Stock (Right to Buy) | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2024 | 1,071,429 | 0 | - | - | Restricted Stock Units | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2024 | 1,071,429 | 2,631,433 (1%) | 0% | - | Common Stock | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2024 | 1,071,429 | 1,071,429 | - | - | Restricted Stock Units | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.40 per share. | 05 Apr 2024 | 410,357 | 2,221,076 (1%) | 0% | 1.4 | 574,500 | Common Stock |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2023 | 141,587 | 0 | - | - | Restricted Stock Units | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2023 | 141,587 | 1,636,973 (0%) | 0% | - | Common Stock | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.53 per share. | 23 Aug 2023 | 76,969 | 1,560,004 (0%) | 0% | 1.5 | 117,763 | Common Stock |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2023 | 141,587 | 141,587 | - | - | Restricted Stock Units | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2023 | 141,587 | 1,551,241 (0%) | 0% | - | Common Stock | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.66 per share. | 16 Aug 2023 | 55,855 | 1,495,386 (0%) | 0% | 1.7 | 92,719 | Common Stock |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2023 | 141,587 | 1,362,373 (0%) | 0% | - | Common Stock | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2023 | 141,587 | 424,760 | - | - | Restricted Stock Units | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.10 per share. | 02 Aug 2023 | 52,870 | 1,309,503 (0%) | 0% | 1.1 | 58,157 | Common Stock |
| Kinnate Biopharma Inc | Helen Sabzevari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 1,732,300 | 1,732,300 | - | - | Option to Purchase Common Stock (Right to Buy) | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2023 | 849,520 | 849,520 | - | - | Restricted Stock Units | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2023 | 369,596 | 369,596 | - | - | Option to Purchase Common Stock (Right to Buy) | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2023 | 283,173 | 566,347 | - | - | Restricted Stock Units | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2023 | 283,173 | 1,220,786 (0%) | 0% | - | Common Stock | |
| Precigen Inc | Helen Sabzevari | President and CEO | Purchase of securities on an exchange or from another person at price $ 1.75 per share. | 27 Jan 2023 | 22,857 | 937,613 (0%) | 0% | 1.8 | 40,000 | Common Stock |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 17,665 | 0 | - | - | Restricted Stock Units | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 17,665 | 914,756 (0%) | 0% | - | Common Stock | |
| Kinnate Biopharma Inc | Helen Sabzevari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 20,250 | 20,250 | - | - | Stock Option (right to buy) | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2022 | 340,909 | 1,075,059 (0%) | 0% | - | Common Stock | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2022 | 340,909 | 0 | - | - | Restricted Stock Units | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.19 per share. | 12 May 2022 | 177,968 | 897,091 (0%) | 0% | 1.2 | 210,928 | Common Stock |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2022 | 340,909 | 340,909 | - | - | Restricted Stock Units | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 847,000 | 847,000 | - | - | Option to Purchase Common Stock (Right to Buy) | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 17,667 | 741,110 (0%) | 0% | - | Common Stock | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 17,667 | 17,665 | - | - | Restricted Stock Units | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.59 per share. | 04 Jan 2022 | 5,603 | 734,150 (0%) | 0% | 3.6 | 20,115 | Common Stock |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.59 per share. | 04 Jan 2022 | 1,357 | 739,753 (0%) | 0% | 3.6 | 4,872 | Common Stock |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2022 | 9,765 | 727,291 (0%) | 0% | - | Common Stock | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2022 | 9,765 | 0 | - | - | Restricted Stock Units | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.67 per share. | 02 Jan 2022 | 3,848 | 723,443 (0%) | 0% | 3.7 | 14,123 | Common Stock |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2021 | 25,000 | 0 | - | - | Restricted Stock Units | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2021 | 25,000 | 730,057 (0%) | 0% | - | Common Stock | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.43 per share. | 17 Jul 2021 | 12,531 | 717,526 (0%) | 0% | 5.4 | 68,047 | Common Stock |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2021 | 97,276 | 752,490 (0%) | 0% | - | Common Stock | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2021 | 97,276 | 0 | - | - | Restricted Stock Units | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.40 per share. | 12 May 2021 | 47,433 | 705,057 (0%) | 0% | 6.4 | 303,571 | Common Stock |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 97,276 | 97,276 | - | - | Restricted Stock Units | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2021 | 500,000 | 915,259 (0%) | 0% | - | Common Stock | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2021 | 500,000 | 0 | - | - | Restricted Stock Units | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 8.92 per share. | 05 Jan 2021 | 260,045 | 655,214 (0%) | 0% | 8.9 | 2,318,535 | Common Stock |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 17,667 | 35,332 | - | - | Restricted Stock Units | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 17,667 | 424,299 (0%) | 0% | - | Common Stock | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.56 per share. | 04 Jan 2021 | 9,040 | 415,259 (0%) | 0% | 10.6 | 95,507 | Common Stock |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2021 | 9,766 | 411,911 (0%) | 0% | - | Common Stock | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2021 | 9,766 | 9,765 | - | - | Restricted Stock Units | |
| Precigen Inc | Helen Sabzevari | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.16 per share. | 02 Jan 2021 | 5,279 | 406,632 (0%) | 0% | 10.2 | 53,635 | Common Stock |